Literature DB >> 26162275

[Adjuvant radiotherapy following radical prostatectomy for prostate cancer].

S Schmidt1, F Zengerling.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26162275     DOI： 10.1007/s00120-015-3871-7

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  10 in total

1.  Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.

Authors:  Thomas Wiegel; Detlef Bartkowiak; Dirk Bottke; Claudia Bronner; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Normann Willich; Axel Semjonow; Michael Stöckle; Christian Rübe; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Rainer Hofmann; Rita Engenhart-Cabillic; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  Eur Urol       Date:  2014-03-21       Impact factor: 20.096

Review 2.  Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis.

Authors:  Scott C Morgan; Tricia S Waldron; Libni Eapen; Linda A Mayhew; Eric Winquist; Himu Lukka
Journal:  Radiother Oncol       Date:  2008-05-22       Impact factor: 6.280

3.  Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Bertrand Tombal; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Marc Colombel; Cees van de Beek; Paul Verhagen; Alphonsus van den Bergh; Cora Sternberg; Thomas Gasser; Geertjan van Tienhoven; Pierre Scalliet; Karin Haustermans; Laurence Collette
Journal:  Lancet       Date:  2012-10-19       Impact factor: 79.321

4.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

5.  Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.

Authors:  Alberto Briganti; Thomas Wiegel; Steven Joniau; Cesare Cozzarini; Marco Bianchi; Maxine Sun; Bertrand Tombal; Karin Haustermans; Tom Budiharto; Wolfgang Hinkelbein; Nadia Di Muzio; Pierre I Karakiewicz; Francesco Montorsi; Hein Van Poppel
Journal:  Eur Urol       Date:  2012-05-16       Impact factor: 20.096

6.  Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.

Authors:  Theodorus H Van der Kwast; Michel Bolla; Hein Van Poppel; Paul Van Cangh; Kris Vekemans; Luigi Da Pozzo; Jean-Francois Bosset; Karl H Kurth; Fritz H Schröder; Laurence Collette
Journal:  J Clin Oncol       Date:  2007-09-20       Impact factor: 44.544

7.  Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.

Authors:  Jochen Walz; Felix K-H Chun; Eric A Klein; Alwyn Reuther; Fred Saad; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Journal:  J Urol       Date:  2008-12-13       Impact factor: 7.450

8.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

9.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors:  Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

10.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Authors:  Ian M Thompson; Catherine M Tangen; Jorge Paradelo; M Scott Lucia; Gary Miller; Dean Troyer; Edward Messing; Jeffrey Forman; Joseph Chin; Gregory Swanson; Edith Canby-Hagino; E David Crawford
Journal:  J Urol       Date:  2009-01-23       Impact factor: 7.450
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.